| Protein glycosylation and tumor microenvironment alterations driving cancer hallmarks A Peixoto, M Relvas-Santos, R Azevedo, LL Santos, JA Ferreira Frontiers in oncology 9, 380, 2019 | 256 | 2019 |
| CD44 glycoprotein in cancer: a molecular conundrum hampering clinical applications R Azevedo, C Gaiteiro, A Peixoto, M Relvas-Santos, L Lima, LL Santos, ... Clinical proteomics 15, 1-5, 2018 | 53 | 2018 |
| Glycoengineered nanoparticles enhance the delivery of 5-fluoroucil and paclitaxel to gastric cancer cells of high metastatic potential E Fernandes, D Ferreira, A Peixoto, R Freitas, M Relvas-Santos, ... International Journal of Pharmaceutics 570, 118646, 2019 | 33 | 2019 |
| Glycan affinity magnetic nanoplatforms for urinary glycobiomarkers discovery in bladder cancer R Azevedo, J Soares, C Gaiteiro, A Peixoto, L Lima, D Ferreira, ... Talanta 184, 347-355, 2018 | 33 | 2018 |
| Nucleolin-Sle A glycoforms as E-selectin ligands and potentially targetable biomarkers at the cell surface of gastric cancer cells E Fernandes, R Freitas, D Ferreira, J Soares, R Azevedo, C Gaiteiro, ... Cancers 12 (4), 861, 2020 | 28 | 2020 |
| Glycoproteomics identifies HOMER3 as a potentially targetable biomarker triggered by hypoxia and glucose deprivation in bladder cancer A Peixoto, D Ferreira, R Azevedo, R Freitas, E Fernandes, ... Journal of Experimental & Clinical Cancer Research 40 (1), 191, 2021 | 23 | 2021 |
| Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto, D Ferreira, P Paulo, ... Theranostics 12 (7), 3150, 2022 | 18 | 2022 |
| Glycoproteogenomics: setting the course for next-generation cancer neoantigen discovery for cancer vaccines JA Ferreira, M Relvas-Santos, A Peixoto, A MN Silva, L Lara Santos Genomics, Proteomics and Bioinformatics 19 (1), 25-43, 2021 | 16 | 2021 |
| Target score—a proteomics data selection tool applied to esophageal cancer identifies GLUT1-sialyl tn glycoforms as biomarkers of cancer aggressiveness S Cotton, D Ferreira, J Soares, A Peixoto, M Relvas-Santos, R Azevedo, ... International Journal of Molecular Sciences 22 (4), 1664, 2021 | 15 | 2021 |
| Protein glycosylation and tumor microenvironment alterations driving Cancer hallmarks. Front Oncol. 2019; 9: 380 A Peixoto, M Relvas-Santos, R Azevedo, LL Santos, JA Ferreira Epub 2019/06/04. https://doi. org/10.3389/fonc. 2019.00380 PMID: 31157165, 2019 | 11 | 2019 |
| Single-pot enzymatic synthesis of cancer-associated MUC16 O-glycopeptide libraries and multivalent protein glycoconjugates: a step towards cancer glycovaccines R Freitas, M Relvas-Santos, R Azevedo, J Soares, E Fernandes, ... New Journal of Chemistry 45 (20), 9197-9211, 2021 | 8 | 2021 |
| Metabolomics, transcriptomics and functional glycomics reveals bladder cancer cells plasticity and enhanced aggressiveness facing hypoxia and glucose deprivation A Peixoto, R Freitas, D Ferreira, M Relvas-Santos, P Paulo, M Cardoso, ... BioRxiv, 2021.02. 14.431133, 2021 | 4 | 2021 |
| Targeted and Self-Adjuvated Nanoglycovaccine Candidate for Cancer Immunotherapy R Freitas, E Ferreira, A Miranda, D Ferreira, M Relvas-Santos, F Castro, ... ACS nano 18 (14), 10088-10103, 2024 | 1 | 2024 |
| A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy R Freitas, A Miranda, D Ferreira, M Relvas-Santos, F Castro, E Ferreira, ... Journal of Controlled Release 367, 540-556, 2024 | 1 | 2024 |
| Multilevel Plasticity and Altered Glycosylation Drive Aggressiveness in Hypoxic and Glucose-Deprived Bladder Cancer Cells A Peixoto, D Ferreira, A Miranda, M Relvas-Santos, R Freitas, TS Veth, ... bioRxiv, 2023.10. 21.561355, 2023 | 1 | 2023 |
| Glycoproteogenomics characterizes the CD44 splicing code driving bladder cancer invasion C Gaiteiro, J Soares, M Relvas-Santos, A Peixoto, D Ferreira, A Brandão, ... bioRxiv, 2021.09. 04.458979, 2021 | 1 | 2021 |
| Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer J Soares, M Eiras, D Ferreira, DAR Santos, M Relvas-Santos, B Santos, ... International Journal of Molecular Sciences 25 (7), 3722, 2024 | | 2024 |
| Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer E Ferreira, D Ferreira, M Relvas-Santos, R Freitas, J Soares, R Azevedo, ... International Journal of Molecular Sciences 25 (6), 3462, 2024 | | 2024 |
| Exploiting Glycoengineered Simple Cells and Bioinformatics-Assisted Glycoproteomics for Bladder Cancer Targets Prioritization M Relvas-Santos, R Freitas, A Peixoto, J Soares, D Ferreira, C Gaiteiro, ... Proteo Vilamoura, 0 | | |
